Source: Medicines and Medical Devices Safety Authority (NZ) Revision Year: 2019 Publisher: Bayer New Zealand Limited, 3 Argus Place, Hillcrest, North Shore, Auckland 0627 Free Phone 0800 233 988 www.bayer.co.nz
ADALAT 10 (nifedipine) modified release tablets.
ADALAT 20 (nifedipine) modified release tablets.
| Pharmaceutical Form |
|---|
|
Tablet: Round to convex, grey-pink coated. |
Each ADALAT 10 modified release tablet contains 10 mg nifedipine.
Each ADALAT 20 modified release tablet contains 20 mg nifedipine.
| Active Ingredient | Description | |
|---|---|---|
| Nifedipine |
Nifedipine is a calcium antagonist of the 1,4-dihydropyridine type. Calcium antagonists reduce the transmembranal influx of calcium ions through the slow calcium channel into the cell. As a specific and potent calcium antagonist, nifedipine acts particularly on the cells of the myocardium and the smooth muscle cells of the coronary arteries and the peripheral resistance vessels. The main action of nifedipine is to relax arterial smooth muscle, both in the coronary and peripheral circulation. Nifedipine Tablets are formulated to achieve controlled delivery of nifedipine in a release profile sufficient to enable once-daily administration to be effective in clinical use. |
| List of Excipients |
|---|
|
ADALAT contains the excipients: Hypromellose |
PP/Alu blister strips of 10 tablets in boxes containing 60 tablets.
Bayer New Zealand Limited, 3 Argus Place, Hillcrest, North Shore, Auckland 0627
Free Phone 0800 233 988
www.bayer.co.nz
Date of first approval: 20 December 1984
| Drug | Countries | |
|---|---|---|
| ADALAT | Austria, Brazil, Canada, Estonia, Spain, Hong Kong, Ireland, Italy, Japan, Mexico, Nigeria, Netherlands, New Zealand, Romania, Singapore, Turkey, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
